| |
| |
Silanol-based product for care of the superficial lymphatic vessels - Patent 5085870 |
 | | Composition according to claim 9, wherein the silanol derivative comprises methyl silane triol lactate and methyl silane triol hyaluronate, and in the proteosilane R is C.sub.2 H.sub.5, n is 2, R.sup.2 is an acetyl tyrosine acid moiety, and R.sup.3 is a solubilized elastine moiety. |
 | | Silanol derivatives which can also be employed include siloxanes, for example of the type ##STR1## where R is a hydrocarbon group and n is a number from 0 to 20, but preferably from 0 to 4. |
 | | The regeneration of collagen and elastine fibres and the restructuring of proteoglucanes, due to the silanol, are accompanied by an intervention in the metabolism of fatty bodies; thus during lipolysis, the silanol favours the formation of unsaturated fatty acids and protects them from cytotoxic peroxydation, capable of raising the viscosity of the lymph. |
| www.freepatentsonline.com /5085870.html (2149 words) |
|